ixekizumab
Showing 26 - 33 of 33
Axial Spondyloarthritis Trial in Worldwide (Ixekizumab, Placebo)
Completed
- Axial Spondyloarthritis
- Ixekizumab
- Placebo
-
Phoenix, Arizona
- +108 more
Feb 28, 2020
Plaque Psoriasis Trial in Germany (Fumaric Acid Esters, Methotrexate, Ixekizumab)
Completed
- Plaque Psoriasis
- Fumaric Acid Esters
- +2 more
-
Augsburg, Germany
- +20 more
Sep 25, 2019
Genital Psoriasis, Psoriasis Trial in Worldwide (Ixekizumab, Placebo)
Completed
- Genital Psoriasis
- Psoriasis
- Ixekizumab
- Placebo
-
Santa Ana, California
- +33 more
Aug 28, 2019
Psoriatic Arthritis Trial in Worldwide (Ixekizumab, Placebo)
Completed
- Psoriatic Arthritis
- Ixekizumab
- Placebo
-
Glendale, Arizona
- +105 more
Oct 25, 2019
Psoriasis, Arthritic Trial in Worldwide (Ixekizumab, Placebo, Adalimumab)
Completed
- Psoriasis, Arthritic
- Ixekizumab
- +2 more
-
Birmingham, Alabama
- +115 more
Dec 16, 2018
Spondylitis, Ankylosing Trial in Worldwide (Ixekizumab, Placebo, Adalimumab)
Withdrawn
- Spondylitis, Ankylosing
- Ixekizumab
- +2 more
-
Birmingham, Alabama
- +125 more
Sep 15, 2014